| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,585 |
2,312 |
$182K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
410 |
371 |
$57K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
269 |
250 |
$20K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
506 |
442 |
$18K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
333 |
296 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
619 |
521 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
35 |
35 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
37 |
36 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
31 |
31 |
$1K |
| 81025 |
|
229 |
195 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
20 |
12 |
$860.35 |
| 99000 |
|
66 |
30 |
$460.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
34 |
27 |
$298.98 |
| 81002 |
|
101 |
94 |
$255.67 |
| 87807 |
|
20 |
17 |
$201.20 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
12 |
$24.06 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
30 |
25 |
$20.78 |